Clorox
1,107 hedge funds and large institutions have $14.7B invested in Clorox in 2022 Q4 according to their latest regulatory filings, with 155 funds opening new positions, 371 increasing their positions, 382 reducing their positions, and 74 closing their positions.
109% more first-time investments, than exits
New positions opened: 155 | Existing positions closed: 74
15% more capital invested
Capital invested by funds: $12.7B → $14.7B (+$1.95B)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
6% more funds holding
Funds holding: 1,045 → 1,107 (+62)
4% more call options, than puts
Call options by funds: $326M | Put options by funds: $312M
0.68% more ownership
Funds ownership: 80.5% → 81.18% (+0.68%)
3% less repeat investments, than reductions
Existing positions increased: 371 | Existing positions reduced: 382
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$96.6M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$44M |
| 3 |
NI
Nuance Investments
Kansas City,
Missouri
|
+$42.4M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$34M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$241M |
| 2 |
Squarepoint
New York
|
-$51.3M |
| 3 |
Amundi
Paris,
France
|
-$32.7M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$28.4M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
-$28.2M |
CLX Hedge Fund Activity: Q4 2022 in Review
1,107 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Clorox (CLX) for Q4 2022, worth a combined $14.7B — up 15% from $12.7B a quarter earlier.
Buyers outnumbered sellers: 155 funds opened new CLX positions and 74 closed out — a net gain of 81 holders — while 371 added to existing stakes and 382 trimmed.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $96.6M. The largest seller was BlackRock, cutting an estimated $241M.
- 1,107 institutional investors held Clorox (CLX) as of Q4 2022, up from 1,045 in Q3 2022.
- Funds reported $14.7B of Clorox stock for Q4 2022, up 15% quarter-over-quarter.
- 155 funds opened new Clorox positions in Q4 2022 and 74 closed out, a net change of +81 holders.
- The largest Clorox buyer in Q4 2022 was Balyasny Asset Management, an estimated $96.6M added.
- The largest Clorox seller in Q4 2022 was BlackRock, an estimated $241M sold.
Based on aggregated 13F filings for Q4 2022.